Search This Blog

Sunday, November 4, 2018

Oppenheimer Analysts Give Exelixis (EXEL) a $40.00 Price Target


Oppenheimer set a $40.00 target price on Exelixis (NASDAQ:EXEL) in a research report report published on Thursday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)